Francine M. Foss

Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994.

F. Foss, H. Koh, M. Demierre, 1997, Journal of the American Academy of Dermatology.

Early detection of cutaneous lymphoma.

F. Foss, H. Koh, M. Demierre, 1998, Oncology.

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.

M. Demierre, Gina DiVenuti, Francine M. Foss, 2005, Blood.

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.

F. Foss, M. Demierre, G. DiVenuti, 2005, Blood.

Combination therapy with purine nucleoside analogs.

F. Foss, Francine M. Foss, 2000, Oncology.

DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma.

F. Foss, Francine M. Foss, 2000, Clinical lymphoma.

DAB(389)IL-2 (denileukin diftitox, ONTAK): a new fusion protein technology.

F. Foss, Francine M. Foss, 2000, Clinical lymphoma.